Example: Heart Attack

Clinical Trials on Genital Neoplasms, Male

Total 4615 results

    • NCT00210041
      Completed
      Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma
      Conditions: Genital Neoplasms, Male
    • NCT02740127
      Recruiting
      Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis
      Conditions: Malignant Neoplasms of Male Genital Organs
    • NCT03035357
      Withdrawn
      Neoadjuvant Listeria or Daratumumab in Prostate Cancer
      Conditions: Malignant Neoplasms of Male Genital Organs; Prostate Cancer
    • NCT01464216
      Recruiting
      MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
      Conditions: Prostatic Neoplasms; Genital Neoplasms, Male; Prostatic Diseases
    • NCT02606123
      Terminated
      Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
      Conditions: Prostatic Neoplasms; Genital Neoplasms, Male; Genital Diseases, Male; Prostatic Diseases
    • NCT01217697
      Approved for marketing
      Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
      Conditions: Prostate Neoplasms; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male
    • NCT01918605
      Terminated
      Protection of Rectum From High Radiation Doses Using a Spacer
      Conditions: Prostatic Neoplasms; Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site
    • NCT03210376
      Completed
      Neuromuscular Blockade on Shoulder Pain of Elderly
      Conditions: Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Urinary Tract
    • NCT02812056
      Withdrawn
      Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
      Conditions: Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs
    • NCT03162627
      Recruiting
      Selumetinib and Olaparib in Solid Tumors
      Conditions: Malignant Neoplasm of Breast; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Thyroid and Other Endocrine Glands
    • NCT03344757
      Recruiting
      Health Gatherings - For Your Health After Cancer
      Conditions: Prostate Neoplasm; Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasm, Prostate; Genital Diseases, Male; Prostatic Diseases
    • NCT04221828
      Recruiting
      Trial of NanoPac Focal Therapy for Prostate Cancer
      Conditions: Prostate Cancer; Prostate Adenocarcinoma; Prostate Cancer Adenocarcinoma; Prostatic Neoplasm; Urogenital Neoplasms; Genital Neoplasms, Male; Localized Cancer
    • NCT02266745
      Recruiting
      A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors
      Conditions: Advanced Solid Tumors; TET: Thymic Epithelia Tumors; CRPC; mCRPC; Metastatic Castrate-resistant Prostate Cancer; PT-112; Prostatic Neoplasms; Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site
    • NCT01540994
      Completed
      Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
      Conditions: Prostatic Neoplasm
    • NCT04461509
      Not yet recruiting
      High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU
      Conditions: Prostatic Neoplasms; Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Prostatic Disease
    • NCT01316458
      Completed
      Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
      Conditions: Prostatic Neoplasm; Genital Neoplasms, Male; Neoplasms, Abdominal; Urogenital Neoplasms; Genital Diseases, Male; Prostatic Diseases; Antineoplastic Agents; Imatinib
    • NCT00672009
      Terminated
      A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
      Conditions: Prostatic Diseases; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male; Adenocarcinoma; Prostatic Neoplasms; Neoplasms, Glandular and Epithelial; Carcinoma
    • NCT02499952
      Terminated
      Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
      Conditions: Germ Cell Neoplasms; Testicular Neoplasms; Non Seminomatous Germ Cell Tumors; Mediastinal Neoplasms; Genital Neoplasms, Male; Genital Neoplasms, Female; Ovarian Neoplasms
    • NCT04249947
      Recruiting
      P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      Conditions: Prostatic Neoplasms, Castration-Resistant; Neoplasms by Histologic Type; Neoplasms, Prostate; Prostate Cancer; Metastatic Castration-resistant Prostate Cancer; Neoplasms; Prostatic Neoplasms; Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Prostatic Disease
    • NCT03420963
      Recruiting
      Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
      Conditions: Recurrent Cutaneous Melanoma; Recurrent Lip and Oral Cavity Carcinoma; Recurrent Malignant Endocrine Neoplasm; Recurrent Malignant Female Reproductive System Neoplasm; Recurrent Malignant Male Reproductive System Neoplasm; Recurrent Malignant Mesothelioma; Recurrent Malignant Neoplasm of Multiple Primary Sites; Recurrent Malignant Oral Neoplasm; Recurrent Malignant Pharyngeal Neoplasm; Recurrent Malignant Skin Neoplasm; Recurrent Malignant Soft Tissue Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Malignant Thyroid Gland Neoplasm; Recurrent Malignant Urinary System Neoplasm; Refractory Cutaneous Melanoma; Refractory Malignant Bone Neoplasm; Refractory Malignant Endocrine Neoplasm; Refractory Malignant Female Reproductive System Neoplasm; Refractory Malignant Male Reproductive System Neoplasm; Refractory Malignant Mesothelioma; Refractory Malignant Neoplasm of Multiple Primary Sites; Refractory Malignant Oral Neoplasm; Refractory Malignant Pharyngeal Neoplasm; Refractory Malignant Skin Neoplasm; Refractory Malignant Soft Tissue Neoplasm; Refractory Malignant Solid Neoplasm; Refractory Malignant Thyroid Gland Neoplasm; Refractory Malignant Urinary System Neoplasm
    • NCT02915172
      Withdrawn
      Lenvatinib and Capecitabine in Patients With Advanced Malignancies
      Conditions: Advanced Cancer; Malignant Neoplasm of Breast; Malignant Neoplasms of Bone and Articular Cartilage; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary Tract
    • NCT03093909
      Recruiting
      Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
      Conditions: Malignant Neoplasm of Bone and Articular Cartilage; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasm of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary Tract; Melanoma and Other Malignant Neoplasms of Skin
    • NCT03435952
      Recruiting
      Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
      Conditions: Malignant Neoplasm of Breast; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary Tract
    • NCT02464696
      Recruiting
      Early Non Invasive Ventilation and Hematological Malignancies
      Conditions: Hematological Malignancies; Chronic Hypoxemic Respiratory Failure; Blood And Marrow Transplantation; Malignant Neoplasm of Breast; Malignant Neoplasms of Bone and Articular Cartilage; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary Tract; Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • NCT02192333
      Completed
      Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
      Conditions: Breast Carcinoma; Cancer Survivor; Depression; Fatigue; Leukemia; Lymphoma; Malignant Bone Neoplasm; Malignant Digestive System Neoplasm; Malignant Female Reproductive System Neoplasm; Malignant Male Reproductive System Neoplasm; Pain; Sleep Disorder; Soft Tissue Sarcoma
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations